Max Kozlov 4 months ago
Researcher Amita Gupta has spent more than a decade planning and running a $70-million trial to study a new tuberculosis drug, enrolling ~6,000 participants in 13 countries. It might all have been for nothing.
That's because a new NIH policy has abruptly cut off billions to trials abroad. đ§Ș